Workup and Management of Native and Prosthetic Valve Endocarditis

被引:5
作者
Bin Abdulhak A.A. [1 ]
Qazi A.H. [1 ]
Tleyjeh I.M. [2 ,3 ,4 ,5 ]
机构
[1] Division of Cardiovascular Medicine, Department of Internal Medicine, University of Iowa Carver College of Medicine, Iowa City, 52242, IA
[2] Division of Infectious Diseases, Mayo Clinic, Rochester, MN
[3] Division of Epidemiology, Mayo Clinic, Rochester, MN
[4] Department of Medicine, Infectious Diseases Section, King Fahad Medical City, PO Box 59046, Riyadh
[5] College of Medicine, Al Faisal University, Riyadh
关键词
Heart failure; Infective endocarditis; Stroke; Valve surgery;
D O I
10.1007/s11936-018-0668-1
中图分类号
学科分类号
摘要
Infective endocarditis (IE) is associated with significant serious adverse outcomes including death. IE usually presents with diverse clinical picture and syndromic diagnoses including heart failure, stroke, and peripheral embolization. Given variable, vague, and syndromic presentations, the diagnosis of IE may be delayed for days to weeks. Maintaining a high index of suspicion among clinicians is the key to early recognition of the disease and prompt initiation of antimicrobial therapy to prevent IE-associated mortality and morbidity. Blood culture and echocardiography remain essential tools in the diagnosis of infective endocarditis. However, advances in molecular techniques, serology testing, computed tomography scan, and nuclear medicine have led to growth in the available tools that may aid in early diagnosis of infective endocarditis. Antimicrobial agents are the mainstay of IE therapy; however, as many as 50% of endocarditis cases will undergo valve surgery, even on an urgent or emergent basis. © 2018, Springer Science+Business Media, LLC, part of Springer Nature.
引用
收藏
相关论文
共 33 条
[1]  
Thuny F., Grisoli D., Cautela J., Riberi A., Raoult D., Habib G., Infective endocarditis: prevention, diagnosis, and management, Can J Cardiol, 30, 9, pp. 1046-1057, (2014)
[2]  
Sy R.W., Kritharides L., Health care exposure and age in infective endocarditis: results of a contemporary population-based profile of 1536 patients in Australia, Eur Heart J, 31, 15, pp. 1890-1897, (2010)
[3]  
Selton-Suty C., Celard M., Le Moing V., Et al., Preeminence of Staphylococcus aureus in infective endocarditis: a 1-year population-based survey, Clin Infect Dis, 54, 9, pp. 1230-1239, (2012)
[4]  
Murray C.J., Vos T., Lozano R., Et al., Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010, Lancet, 380, 9859, pp. 2197-2223, (2012)
[5]  
Habib G., Lancellotti P., Antunes M.J., Et al., ESC guidelines for the management of infective endocarditis: the Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM), Eur Heart J, 36, 44, pp. 3075-3128, (2015)
[6]  
Bin Abdulhak A.A., Baddour L.M., Erwin P.J., Et al., Global and regional burden of infective endocarditis, 1990–2010: a systematic review of the literature, Glob Heart, 9, 1, pp. 131-143, (2014)
[7]  
Hoen B., Duval X., Infective endocarditis, N Engl J Med, 369, 8, (2013)
[8]  
Tleyjeh I.B.A.A., Infective endocarditis: epidemiology, diagnosis, imaging, therapy, and prevention: definition and epidemiology of infective endocarditis, (2016)
[9]  
Correa de Sa D.D., Tleyjeh I.M., Anavekar N.S., Et al., Epidemiological trends of infective endocarditis: a population-based study in Olmsted County, Minnesota, Mayo Clin Proc, 85, 5, pp. 422-426, (2010)
[10]  
Vogkou C.T., Vlachogiannis N.I., Palaiodimos L., Kousoulis A.A., The causative agents in infective endocarditis: a systematic review comprising 33,214 cases, Eur J Clin Microbiol Infect Dis, 35, 8, pp. 1227-1245, (2016)